Xeris Biopharma Holdings Inc (XERS)

Nov 21, 2025

What drives Xeris Biopharma Holdings Inc 2B30 stock priceDividend Stability Analysis & Stay Safe With Built-In Risk Monitoring - earlytimes.in

Nov 21, 2025

Nov 21, 2025

Xeris Biopharma Faces Weak Start with 15% Gap Down Amid Market Concerns - Markets Mojo

Nov 21, 2025

Nov 20, 2025

How higher bond yields impact Xeris Biopharma Holdings Inc. (2B30) stockIndex Update & Accurate Entry/Exit Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Will Xeris Biopharma Holdings Inc. (2B30) stock hit Wall Street targetsPortfolio Value Summary & Low Drawdown Investment Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

Will Xeris Biopharma Holdings Inc. stock deliver long term returns2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com

Nov 19, 2025

Nov 18, 2025

Detecting support and resistance levels for Xeris Biopharma Holdings Inc.2025 Year in Review & Verified Stock Trade Ideas - newser.com

Nov 18, 2025

Nov 16, 2025

Why Xeris Biopharma Holdings Inc. (2B30) stock appeals to dividend investorsJuly 2025 Rallies & Daily Chart Pattern Signals - newser.com

Nov 16, 2025

Nov 16, 2025

Xeris Biopharma (XERS): Valuation Insights After New Recorlev Patent, Profit Boost, and 2025 Outlook Upgrade - Sahm

Nov 16, 2025

Nov 15, 2025

What high frequency data says about Xeris Biopharma Holdings Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

How sentiment analysis helps forecast Xeris Biopharma Holdings Inc.Trade Volume Report & Long-Term Safe Investment Ideas - newser.com

Nov 15, 2025

Nov 15, 2025

How Raised 2025 Revenue Guidance and Q3 Profitability Will Impact Xeris Biopharma (XERS) Investors - Sahm

Nov 15, 2025

Nov 14, 2025

Hecht Beth, chief legal officer, sells Xeris Biopharma (XERS) shares for $123k - Investing.com India

Nov 14, 2025

Nov 12, 2025

Officer Hecht Files To Sell 66,668 Of Xeris Biopharma Holdings Inc [XERS] - TradingView

Nov 12, 2025

Nov 11, 2025

Is Xeris Biopharma Holdings Inc. (2B30) stock supported by strong fundamentalsIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com

Nov 11, 2025

Nov 11, 2025

Why Xeris Biopharma Holdings Inc. (2B30) stock is listed among top recommendationsTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 11, 2025

Nov 10, 2025

Is Xeris Biopharma Holdings Inc. (2B30) stock cheap vs fundamentalsJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com

Nov 10, 2025

Nov 10, 2025

Is a relief rally coming for Xeris Biopharma Holdings Inc. holdersStock Surge & Community Consensus Stock Picks - newser.com

Nov 10, 2025

Nov 10, 2025

Why Xeris Biopharma Holdings Inc. (2B30) stock could be top winnerWeekly Stock Summary & Daily Stock Trend Reports - newser.com

Nov 10, 2025

Nov 10, 2025

Is Xeris Biopharma Holdings Inc. stock entering bullish territoryJuly 2025 Review & Risk Controlled Stock Alerts - newser.com

Nov 10, 2025

Nov 09, 2025

Applying chart zones and confluence areas to Xeris Biopharma Holdings Inc.Oil Prices & Consistent Growth Equity Picks - newser.com

Nov 09, 2025

Nov 09, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 09, 2025

Nov 08, 2025

Q4 2024 Xeris Biopharma Holdings Inc Earnings Call Transcript - GuruFocus

Nov 08, 2025

Nov 08, 2025

Xeris Biopharma (XERS) Turns Profitable and Lifts 2025 Outlook but What Will Sustain Growth? - Sahm

Nov 08, 2025

Nov 07, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 07, 2025

Nov 07, 2025

Xeris raises 2025 revenue guidance to $285M-$290M as RECORLEV revenue more than doubles year-over-year - MSN

Nov 07, 2025

Nov 07, 2025

Xeris Biopharma Holdings, Inc. (2B30.F) stock price, news, quote and history - Yahoo Finance Singapore

Nov 07, 2025

Nov 07, 2025

Xeris Biopharma Hits Day Low at $7.00 Amid Price Pressure - Markets Mojo

Nov 07, 2025

Nov 07, 2025

Xeris Biopharma Holdings Inc (XERS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 07, 2025

Nov 07, 2025

Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025 - BioSpace

Nov 07, 2025

Nov 07, 2025

Assessing Xeris Biopharma (XERS) Valuation Following Strong Q3 Earnings and Raised Revenue Guidance - simplywall.st

Nov 07, 2025